The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blood Screening and Typing Market Research Report 2025
Synopsis
Blood Screening definition: because can transmit a variety of serious infectious diseases such as hepatitis b, hepatitis c, AIDS and syphilis through blood.In order to ensure the safety of blood for clinical use, the quality of blood products, and to prevent cross-infection between blood supplies and the health of workers who collect blood and blood products, it is necessary to prevent the patients infected with the above diseases from entering the blood supply team, and prevent the direct transfusion of plasma positive for the pathogens of the above diseases to patients or for the production of blood products.
The global Blood Screening and Typing market was valued at US$ 6668.3 million in 2023 and is anticipated to reach US$ 8357.6 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Screening and Typing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Screening and Typing.
Report Scope
The Blood Screening and Typing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Screening and Typing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Screening and Typing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agena Bioscience
Axo Science
Bag Health Care Gmbh
Becton, Dickinson
Bio-Rad Laboratories
Biomerieux
Danaher
Day Medical
Diagast
F. Hoffmann-La Roche
Grifols
Immucor
Novacyt Group
Ortho Clinical Diagnostics
Quotient
Siemens Healthcare
Thermo Fisher Scientific
Segment by Type
Nucleic Acid Amplification Technology
Immunohematology
Microbiological Technique
Other
Segment by Application
Reference Laboratories
Standalone Blood Banks
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Screening and Typing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Blood Screening definition: because can transmit a variety of serious infectious diseases such as hepatitis b, hepatitis c, AIDS and syphilis through blood.In order to ensure the safety of blood for clinical use, the quality of blood products, and to prevent cross-infection between blood supplies and the health of workers who collect blood and blood products, it is necessary to prevent the patients infected with the above diseases from entering the blood supply team, and prevent the direct transfusion of plasma positive for the pathogens of the above diseases to patients or for the production of blood products.
The global Blood Screening and Typing market was valued at US$ 6668.3 million in 2023 and is anticipated to reach US$ 8357.6 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Screening and Typing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Screening and Typing.
Report Scope
The Blood Screening and Typing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Screening and Typing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Screening and Typing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Agena Bioscience
Axo Science
Bag Health Care Gmbh
Becton, Dickinson
Bio-Rad Laboratories
Biomerieux
Danaher
Day Medical
Diagast
F. Hoffmann-La Roche
Grifols
Immucor
Novacyt Group
Ortho Clinical Diagnostics
Quotient
Siemens Healthcare
Thermo Fisher Scientific
Segment by Type
Nucleic Acid Amplification Technology
Immunohematology
Microbiological Technique
Other
Segment by Application
Reference Laboratories
Standalone Blood Banks
Hospitals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Screening and Typing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Screening and Typing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nucleic Acid Amplification Technology
1.2.3 Immunohematology
1.2.4 Microbiological Technique
1.2.5 Other
1.3 Market by Application
1.3.1 Global Blood Screening and Typing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Reference Laboratories
1.3.3 Standalone Blood Banks
1.3.4 Hospitals
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Screening and Typing Market Perspective (2019-2030)
2.2 Blood Screening and Typing Growth Trends by Region
2.2.1 Global Blood Screening and Typing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Screening and Typing Historic Market Size by Region (2019-2024)
2.2.3 Blood Screening and Typing Forecasted Market Size by Region (2025-2030)
2.3 Blood Screening and Typing Market Dynamics
2.3.1 Blood Screening and Typing Industry Trends
2.3.2 Blood Screening and Typing Market Drivers
2.3.3 Blood Screening and Typing Market Challenges
2.3.4 Blood Screening and Typing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Screening and Typing Players by Revenue
3.1.1 Global Top Blood Screening and Typing Players by Revenue (2019-2024)
3.1.2 Global Blood Screening and Typing Revenue Market Share by Players (2019-2024)
3.2 Global Blood Screening and Typing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Screening and Typing Revenue
3.4 Global Blood Screening and Typing Market Concentration Ratio
3.4.1 Global Blood Screening and Typing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Screening and Typing Revenue in 2023
3.5 Blood Screening and Typing Key Players Head office and Area Served
3.6 Key Players Blood Screening and Typing Product Solution and Service
3.7 Date of Enter into Blood Screening and Typing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Screening and Typing Breakdown Data by Type
4.1 Global Blood Screening and Typing Historic Market Size by Type (2019-2024)
4.2 Global Blood Screening and Typing Forecasted Market Size by Type (2025-2030)
5 Blood Screening and Typing Breakdown Data by Application
5.1 Global Blood Screening and Typing Historic Market Size by Application (2019-2024)
5.2 Global Blood Screening and Typing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Screening and Typing Market Size (2019-2030)
6.2 North America Blood Screening and Typing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Screening and Typing Market Size by Country (2019-2024)
6.4 North America Blood Screening and Typing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Screening and Typing Market Size (2019-2030)
7.2 Europe Blood Screening and Typing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Screening and Typing Market Size by Country (2019-2024)
7.4 Europe Blood Screening and Typing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Screening and Typing Market Size (2019-2030)
8.2 Asia-Pacific Blood Screening and Typing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Screening and Typing Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Screening and Typing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Screening and Typing Market Size (2019-2030)
9.2 Latin America Blood Screening and Typing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Screening and Typing Market Size by Country (2019-2024)
9.4 Latin America Blood Screening and Typing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Screening and Typing Market Size (2019-2030)
10.2 Middle East & Africa Blood Screening and Typing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Screening and Typing Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Screening and Typing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Blood Screening and Typing Introduction
11.1.4 Abbott Laboratories Revenue in Blood Screening and Typing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Agena Bioscience
11.2.1 Agena Bioscience Company Detail
11.2.2 Agena Bioscience Business Overview
11.2.3 Agena Bioscience Blood Screening and Typing Introduction
11.2.4 Agena Bioscience Revenue in Blood Screening and Typing Business (2019-2024)
11.2.5 Agena Bioscience Recent Development
11.3 Axo Science
11.3.1 Axo Science Company Detail
11.3.2 Axo Science Business Overview
11.3.3 Axo Science Blood Screening and Typing Introduction
11.3.4 Axo Science Revenue in Blood Screening and Typing Business (2019-2024)
11.3.5 Axo Science Recent Development
11.4 Bag Health Care Gmbh
11.4.1 Bag Health Care Gmbh Company Detail
11.4.2 Bag Health Care Gmbh Business Overview
11.4.3 Bag Health Care Gmbh Blood Screening and Typing Introduction
11.4.4 Bag Health Care Gmbh Revenue in Blood Screening and Typing Business (2019-2024)
11.4.5 Bag Health Care Gmbh Recent Development
11.5 Becton, Dickinson
11.5.1 Becton, Dickinson Company Detail
11.5.2 Becton, Dickinson Business Overview
11.5.3 Becton, Dickinson Blood Screening and Typing Introduction
11.5.4 Becton, Dickinson Revenue in Blood Screening and Typing Business (2019-2024)
11.5.5 Becton, Dickinson Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Blood Screening and Typing Introduction
11.6.4 Bio-Rad Laboratories Revenue in Blood Screening and Typing Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Biomerieux
11.7.1 Biomerieux Company Detail
11.7.2 Biomerieux Business Overview
11.7.3 Biomerieux Blood Screening and Typing Introduction
11.7.4 Biomerieux Revenue in Blood Screening and Typing Business (2019-2024)
11.7.5 Biomerieux Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher Blood Screening and Typing Introduction
11.8.4 Danaher Revenue in Blood Screening and Typing Business (2019-2024)
11.8.5 Danaher Recent Development
11.9 Day Medical
11.9.1 Day Medical Company Detail
11.9.2 Day Medical Business Overview
11.9.3 Day Medical Blood Screening and Typing Introduction
11.9.4 Day Medical Revenue in Blood Screening and Typing Business (2019-2024)
11.9.5 Day Medical Recent Development
11.10 Diagast
11.10.1 Diagast Company Detail
11.10.2 Diagast Business Overview
11.10.3 Diagast Blood Screening and Typing Introduction
11.10.4 Diagast Revenue in Blood Screening and Typing Business (2019-2024)
11.10.5 Diagast Recent Development
11.11 F. Hoffmann-La Roche
11.11.1 F. Hoffmann-La Roche Company Detail
11.11.2 F. Hoffmann-La Roche Business Overview
11.11.3 F. Hoffmann-La Roche Blood Screening and Typing Introduction
11.11.4 F. Hoffmann-La Roche Revenue in Blood Screening and Typing Business (2019-2024)
11.11.5 F. Hoffmann-La Roche Recent Development
11.12 Grifols
11.12.1 Grifols Company Detail
11.12.2 Grifols Business Overview
11.12.3 Grifols Blood Screening and Typing Introduction
11.12.4 Grifols Revenue in Blood Screening and Typing Business (2019-2024)
11.12.5 Grifols Recent Development
11.13 Immucor
11.13.1 Immucor Company Detail
11.13.2 Immucor Business Overview
11.13.3 Immucor Blood Screening and Typing Introduction
11.13.4 Immucor Revenue in Blood Screening and Typing Business (2019-2024)
11.13.5 Immucor Recent Development
11.14 Novacyt Group
11.14.1 Novacyt Group Company Detail
11.14.2 Novacyt Group Business Overview
11.14.3 Novacyt Group Blood Screening and Typing Introduction
11.14.4 Novacyt Group Revenue in Blood Screening and Typing Business (2019-2024)
11.14.5 Novacyt Group Recent Development
11.15 Ortho Clinical Diagnostics
11.15.1 Ortho Clinical Diagnostics Company Detail
11.15.2 Ortho Clinical Diagnostics Business Overview
11.15.3 Ortho Clinical Diagnostics Blood Screening and Typing Introduction
11.15.4 Ortho Clinical Diagnostics Revenue in Blood Screening and Typing Business (2019-2024)
11.15.5 Ortho Clinical Diagnostics Recent Development
11.16 Quotient
11.16.1 Quotient Company Detail
11.16.2 Quotient Business Overview
11.16.3 Quotient Blood Screening and Typing Introduction
11.16.4 Quotient Revenue in Blood Screening and Typing Business (2019-2024)
11.16.5 Quotient Recent Development
11.17 Siemens Healthcare
11.17.1 Siemens Healthcare Company Detail
11.17.2 Siemens Healthcare Business Overview
11.17.3 Siemens Healthcare Blood Screening and Typing Introduction
11.17.4 Siemens Healthcare Revenue in Blood Screening and Typing Business (2019-2024)
11.17.5 Siemens Healthcare Recent Development
11.18 Thermo Fisher Scientific
11.18.1 Thermo Fisher Scientific Company Detail
11.18.2 Thermo Fisher Scientific Business Overview
11.18.3 Thermo Fisher Scientific Blood Screening and Typing Introduction
11.18.4 Thermo Fisher Scientific Revenue in Blood Screening and Typing Business (2019-2024)
11.18.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
